Policy Fatigue and the Future of Patient Access in Pharma

Sponsored by BGB Group

Dane Schroeder, EVP of Payer & Access Communications at BGB Group, explores the growing impact of “policy fatigue” as affordability pressures rise and traditional coverage pathways struggle to keep pace with innovation. In this episode, Schroeder shares how pharma organizations can rethink access strategy, pricing models, and patient support to close the gap between coverage and real-world access.

Schroeder pinpoints the specific barriers that cause patient treatment abandonment, spanning from utilization management techniques like prior authorizations to complex affordability programs. Success amidst this legislative whiplash requires that pharma companies start access planning years before launch to break down organizational silos between brand, medical, and patient services teams to ensure life-changing therapies actually reach the patients who need them.